Masakazu Fukuda

Title: Masakazu Fukuda: Innovator in Pharmaceutical Formulations

Introduction

Masakazu Fukuda is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of antibody-based therapies. With a total of 3 patents to his name, Fukuda's work has the potential to impact the treatment of various medical conditions.

Latest Patents

Fukuda's latest patents include a pharmaceutical formulation comprising an aqueous solution of an antibody. This formulation is designed to reduce particle formation and includes a bispecific monoclonal antibody that substitutes for coagulation factor VIII, as well as an anti-IL-6 receptor antibody that inhibits binding to the interleukin 6 receptor. Another notable patent involves antibody variants and isoforms with lowered biological activity. These variants have reduced FVIII mimetic activity compared to Emicizumab and include specific amino acid residues that are cleaved out, as well as isoforms with inter-heavy chain disulfide bonds that are less susceptible to reduction under mild conditions.

Career Highlights

Throughout his career, Fukuda has worked with notable companies such as Chugai Seiyaku Kabushiki Kaisha and Hoffmann-La Roche Inc. His experience in these organizations has allowed him to refine his expertise in pharmaceutical development and innovation.

Collaborations

Fukuda has collaborated with esteemed colleagues, including Satoshi Saitoh and Akira Hayasaka. These partnerships have contributed to the advancement of his research and the successful development of his patented formulations.

Conclusion

Masakazu Fukuda's innovative work in pharmaceutical formulations showcases his dedication to improving medical treatments through advanced antibody technologies. His contributions are poised to make a significant impact in the field of medicine.